APA (7th ed.) Citation

L, N., Y, W., F, Z., YH, H., LC, C., W, X., . . . MC, H. (2020). Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. Nature communications, 11(1), 673. https://doi.org/10.1038/s41467-020-14429-3

Chicago Style (17th ed.) Citation

L, Nie, et al. "Author Correction: CDK2-mediated Site-specific Phosphorylation of EZH2 Drives and Maintains Triple-negative Breast Cancer." Nature Communications 11, no. 1 (2020): 673. https://doi.org/10.1038/s41467-020-14429-3.

MLA (9th ed.) Citation

L, Nie, et al. "Author Correction: CDK2-mediated Site-specific Phosphorylation of EZH2 Drives and Maintains Triple-negative Breast Cancer." Nature Communications, vol. 11, no. 1, 2020, p. 673, https://doi.org/10.1038/s41467-020-14429-3.